| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 90316 |
3,6-二氨基-1,2,4,5-四嗪-1,4-二氧化物 |
195 |
WYQ |
2024-12-03 |
| 90317 |
1,6-二氢-1,2,4,5-四嗪化合物(1,6-Dihydro-1,2,4,5-Tetrazines) |
265 |
WYQ |
2024-12-03 |
| 90318 |
TCO-CC49 ,TCO功能化CC49抗体 |
250 |
wyh |
2024-12-03 |
| 90319 |
[111In]In-DOTA-PEG11-BisPy-Tz |
202 |
WYQ |
2024-12-03 |
| 90320 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
160 |
WYQ |
2024-12-03 |
| 90321 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
166 |
WYQ |
2024-12-03 |
| 90322 |
3,6-双(2-吡啶基)-1,2,4,5-四嗪(bptz);3,6-bis(2-pyridyl)-1,2,4,5-tetrazine |
212 |
WYQ |
2024-12-03 |
| 90323 |
(DOTA)5-decalysine , (DOTA)5-十氢赖氨酸 |
148 |
wyh |
2024-12-03 |
| 90324 |
3,6-dihydrazino-1,2,4,5-tetrazine(DHT) |
178 |
WYQ |
2024-12-03 |
| 90325 |
5-TAMRA-Tz;S-四嗪近红外花菁染料;5-TAMRA-tetrazine |
194 |
WYQ |
2024-12-03 |
| 90326 |
[64Cu]Cu-SarAr-Tz;(64)Cu标记四嗪放射性配体 |
334 |
WYQ |
2024-12-03 |
| 90327 |
DOTA-monoamide,DOTA-单酰胺复合物 |
149 |
wyh |
2024-12-03 |
| 90328 |
DOTA-PEG-RGD, DOTA-聚乙二醇-多肽 |
244 |
wyh |
2024-12-03 |
| 90329 |
DOTA-PEGn-Cys-VS ,单分散PEG偶联螯合剂DO |
181 |
wyh |
2024-12-03 |
| 90330 |
甲氧基DOTA ,MeO-DOTA |
360 |
wyh |
2024-12-03 |
| 90331 |
DOTA-BASS , DOTA偶联sst拮抗剂 |
352 |
wyh |
2024-12-03 |
| 90332 |
DOTA-phenylalanine,DOTA-苯丙氨酸 |
177 |
wyh |
2024-12-03 |
| 90333 |
DOTA−Lysine−Biotin, DOTA -赖氨酸-生物素 |
173 |
wyh |
2024-12-03 |
| 90334 |
DOTA-GA,螯合剂DOTA肽缀合物 |
188 |
wyh |
2024-12-03 |
| 90335 |
DOTA共轭二膦酸盐,DOTA-HBP |
183 |
wyh |
2024-12-03 |
| 90336 |
DOTA-神经介素n ,DOTA-Neuromedin N |
175 |
wyh |
2024-12-03 |
| 90337 |
tris-烯丙基-DOTA , tris-allyl-DOTA |
171 |
wyh |
2024-12-03 |
| 90338 |
6-(苄氧羰基)氨基-3-(甲硫基)-1,2,4-四嗪;6-(benzyloxycarbonyl)amino-3-(methylthio)-1,2,4,5-tetrazine |
169 |
WYQ |
2024-12-03 |
| 90339 |
6-(乙酰氨基)-3-(甲硫基)-1,2,4-四嗪;6-(acetylamino)-3-(methylthio)-1,2,4,5-tetrazine |
193 |
WYQ |
2024-12-03 |
| 90340 |
cFLFLFK-PEG-DOTA ;细胞特异性肽-聚乙二醇-DOTA |
154 |
wyh |
2024-12-03 |
| 90341 |
6-[(叔丁氧基羰基)氨基]-3-(甲硫基)-1,2,4-四嗪;6-[(tert-butyloxycarbonyl)amino]-3-(methylthio)-1,2,4,5-tetrazine |
173 |
WYQ |
2024-12-03 |
| 90342 |
MMA-DOTA-Cys 61 ,DOTA-马来酰亚胺-半胱氨酸 |
218 |
wyh |
2024-12-03 |
| 90343 |
DOTA-BR96 ,DOTA标记BR96单克隆抗体 |
189 |
wyh |
2024-12-03 |
| 90344 |
DOTA-ggNle-cycmsh(hex),内酰胺桥环化肽偶联DOTA |
178 |
wyh |
2024-12-03 |
| 90345 |
DOTA-sCCK8[Phe2(p-CH2SO3H) ,大环DOTA偶联多肽 |
182 |
wyh |
2024-12-03 |
| 90346 |
3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四嗪(BTATz);3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)- 1,2,4,5-tetrazine |
172 |
WYQ |
2024-12-03 |
| 90347 |
3,3'-偶氮二(6-氨基-1,2,4,5-四嗪)(DAAT);3,3'-azobis(6-amino-1,2,4,5-tetrazine) |
362 |
WYQ |
2024-12-03 |
| 90348 |
c(DOTA-RGDf),大环螯合剂DOTA环化RGD肽序列 |
209 |
wyh |
2024-12-03 |
| 90349 |
3,6-双(吡啶-3-基)-1,2,4,5-四嗪(3,3'-吡喃);3,6-bis(pyridin-3-yl)-1,2,4,5-tetrazine (3,3'-pytz) |
192 |
WYQ |
2024-12-03 |
| 90350 |
3,6-双(2-甲氧基苯基)-1,2-二氢-1,2,4,5-四嗪(2-MDHT);3,6-bis(2-methoxyphenyl)-1,2-dihydro-1,2,4,5-tetrazine |
193 |
WYQ |
2024-12-03 |
| 90351 |
3,6-二甲基-1,2,4,5-四嗪;3,6-Dimethyl-1,2,4,5-tetrazine |
207 |
WYQ |
2024-12-03 |
| 90352 |
3,3'-偶氮(6-氨基-1,2,4,5-四嗪);3,3'-Azobis(6-amino-1,2,4,5-tetrazine)(DAAT) |
228 |
WYQ |
2024-12-03 |
| 90353 |
3,6-d二肼基-1,2,4,5-四嗪(DHT) |
177 |
WYQ |
2024-12-03 |
| 90354 |
DOTA-D-phe1-Tyr3-奥曲肽 ,Ga-68-DOTA-TATE |
166 |
wyh |
2024-12-03 |
| 90355 |
DOTA-cCCK,DOTA偶联胆囊收缩素(CCK)受体 |
304 |
wyh |
2024-12-03 |
| 90356 |
3,6-d氨基-1,2,4,5-四嗪(DATZ) |
203 |
WYQ |
2024-12-03 |
| 90357 |
3-d氨基-6-(3,5-二甲基乙基吡唑-1-基)-1,2,4,5-四嗪(ADMPT) |
257 |
WYQ |
2024-12-03 |
| 90358 |
[DOTA]LTT-SS28 ,生长抑素模拟物 |
228 |
wyh |
2024-12-03 |
| 90359 |
DOTA-minigastrin (CP04) , DOTA-小胃泌素(CP04) |
282 |
wyh |
2024-12-03 |
| 90360 |
DOTA-rhuEpo ; DOTA-酰肼偶联rhuEpo |
153 |
wyh |
2024-12-03 |